Lebanon has recorded its first case of the often-fatal Middle East respiratory virus, the Health Ministry said Friday.
The virus was detected Thursday in a man who had checked into a local hospital after feeling ill, the ministry said. It said the case was not severe, and the man has since been discharged.
A ministry official said the patient had recently returned from a visit to several Gulf countries, including Saudi Arabia.
The kingdom has been the focal point of the outbreak of the virus, known as the Middle East Respiratory Syndrome.
MERS belongs to a family of viruses that include both the common cold and SARS, which killed some 800 people in a global outbreak in 2003. It can cause symptoms that include fever, breathing problems, pneumonia and kidney failure.
Not everyone who contracts the virus that causes MERS gets sick, while others show only mild symptoms. There is no cure or vaccine.
Still, the threat from the virus has prompted health officials around the region to adopt protective measures to try to prevent the spread of the disease.
In Lebanon, the health minister on Thursday ordered that thermal cameras be set up at Beirut's international airport to check arriving passengers for possible signs of fever, indicating a possible MERS infection.
Five more people have died in Saudi Arabia after contracting an often fatal Middle East respiratory virus as the number of new infections in the kingdom climbs higher, health officials confirmed Thursday.
(HealthDay)—For patients with upper-extremity deep vein thrombosis (DVT), six easily available factors can be used to create a score that identifies those at low risk of adverse events during the first ...
Cerebral palsy (CP) is the most common cause of childhood disability in the world, affecting between 1 and 2 infants per thousand. But the neurological condition tends to be understudied, especially in developing countries.
A recent discovery by drug researchers whereby coupling specific cell membrane receptors has altered kidney cell function has triggered a re-think of how to treat chronic kidney disease (CKD) more effectively.
In the German Center for Infection Research (DZIF), scientists have conducted clinical studies on an active substance against the dreaded hospital pathogen Staphylococcus aureus: a highly effective protein from bacteriophages ...
Tuberculosis (TB) represents a growing worldwide healthcare burden. Second only to HIV in terms of its global impact, TB infected 8.5 million people and caused 1.4 million deaths in 2011. If these statistics ...
Please sign in to add a comment.
Registration is free, and takes less than a minute.
Click here to reset your password.
Sign in to get notified via email when new comments are made.